Response to Samanta "Are Ketamine Infusions a Viable Therapeutic Option for Refractory Neonatal Seizures?".

Pediatr Neurol

Clinical Associate Professor, Division of Pediatric Neurology, Department of Pediatrics, University of Saskatchewan, Saskatoon, Canada. Electronic address:

Published: May 2020

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pediatrneurol.2020.02.001DOI Listing

Publication Analysis

Top Keywords

response samanta
4
samanta "are
4
"are ketamine
4
ketamine infusions
4
infusions viable
4
viable therapeutic
4
therapeutic option
4
option refractory
4
refractory neonatal
4
neonatal seizures?"
4

Similar Publications

Purpose: Neoadjuvant chemotherapy followed by esophagectomy is the usual approach to manage esophageal squamous cell carcinoma (ESCC). The optimal interval to operate after completion of neoadjuvant chemoradiotherapy (NACRT) still remains controversial.

Methods: A prospective study was conducted to observe and compare postoperative complications and pathological outcomes in patients with squamous cell carcinoma of the esophagus who underwent NACRT followed by surgery within 8 weeks or after 8 weeks of NACRT completion.

View Article and Find Full Text PDF

Reactive oxygen species (ROS) play crucial roles in both cell signaling and defense mechanisms. Hypochlorous acid (HOCl), a strong oxidant, aids the immune response by damaging pathogens. In this study, we developed two pyridinium-based fluorophores PSSM and PSSE for selective hypochlorite detection.

View Article and Find Full Text PDF

Lennox-Gastaut syndrome (LGS) is a severe developmental and epileptic encephalopathy characterized by multiple drug-resistant seizure types, cognitive impairment, and distinctive electroencephalographic patterns. Neuromodulation techniques, including vagus nerve stimulation (VNS), deep brain stimulation (DBS), and responsive neurostimulation (RNS), have emerged as important treatment options for patients with LGS who do not respond adequately to antiseizure medications. This review, developed with input from the Pediatric Epilepsy Research Consortium (PERC) LGS Special Interest Group, provides practical guidance for clinicians on the use of these neuromodulation approaches in patients with LGS.

View Article and Find Full Text PDF
Article Synopsis
  • Zolbetuximab is a chimeric monoclonal antibody designed to target the Claudin 18.2 protein, which is overexpressed in certain gastrointestinal cancers, notably gastric and gastroesophageal junction adenocarcinomas.
  • This drug initiates an immune response to attack cancer cells when combined with standard chemotherapy regimens, and it has been approved as a first-line treatment for advanced, unresectable cancers in specific patient populations.
  • Clinical trials show that zolbetuximab significantly improves progression-free survival and overall survival rates compared to chemotherapy alone, while maintaining a relatively safe profile for patients.
View Article and Find Full Text PDF

In response to climate change mitigation efforts, improving the efficiency of heat networks is becoming increasingly important. An efficient operation of energy systems depends on faultless performance. Following the need for effective fault detection and elimination methods, this study suggests a three-step workflow for increasing automation in managing defective substations on the user level within heat networks.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!